Short C, Byrne L, Hagan-Bezgin A, Quinlan R, Anderson J, Brook G
Pathogens. 2024; 13(4).
PMID: 38668263
PMC: 11054990.
DOI: 10.3390/pathogens13040308.
Moreno S, Rivero A, Ventayol P, Falco V, Torralba M, Schroeder M
Infect Dis Ther. 2023; 12(8):2039-2055.
PMID: 37452174
PMC: 10505114.
DOI: 10.1007/s40121-023-00840-y.
Burtle D, Marsh S, Matin N
BJA Educ. 2023; 23(7):264-272.
PMID: 37389279
PMC: 10300469.
DOI: 10.1016/j.bjae.2023.03.004.
Ruiz-Burga E, Tariq S, Touloumi G, Gill J, Nicholls E, Sabin C
BMJ Open. 2023; 13(5):e070837.
PMID: 37169505
PMC: 10186449.
DOI: 10.1136/bmjopen-2022-070837.
Namagga J, Nambozi G, Rukundo G, Niyonzima V, Batwala V
Pan Afr Med J. 2023; 44:17.
PMID: 37013204
PMC: 10066607.
DOI: 10.11604/pamj.2023.44.17.33844.
A systematic review and meta-analysis assessing antiretroviral therapy for treatment-experienced HIV adult patients using an optimized background therapy approach: is there evidence enough for a standardized third-line strategy?.
Mocellin L, Ziegelmann P, Kuchenbecker R
Syst Rev. 2022; 11(1):243.
PMID: 36397111
PMC: 9673282.
DOI: 10.1186/s13643-022-02102-3.
Re-assessing the late HIV diagnosis surveillance definition in the era of increased and frequent testing.
Kirwan P, Croxford S, Aghaizu A, Murphy G, Tosswill J, Brown A
HIV Med. 2022; 23(11):1127-1142.
PMID: 36069144
PMC: 7613879.
DOI: 10.1111/hiv.13394.
Incidence and Predictors of Virological Failure Among Adult HIV/AIDS Patients on Second-Line Anti-Retroviral Therapy, in Selected Public Hospital of Addis Ababa, Ethiopia: Retrospective Follow-Up Study.
Zakaria H, Raru T, Hassen F, Ayana G, Merga B, Debele G
HIV AIDS (Auckl). 2022; 14:319-329.
PMID: 35836751
PMC: 9275424.
DOI: 10.2147/HIV.S367677.
The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with....
Lee M, Collins S, Babalis D, Johnson N, Falaschetti E, Prevost A
Trials. 2022; 23(1):263.
PMID: 35382844
PMC: 8981886.
DOI: 10.1186/s13063-022-06151-w.
The Immunogenetics of Cutaneous Drug Reactions.
Khalili N
Adv Exp Med Biol. 2022; 1367:411-431.
PMID: 35286706
DOI: 10.1007/978-3-030-92616-8_17.
Response to 'The use of tenofovir in patients with COVID-19'.
Lee M, Nori A, Fidler S, Kulasegaram R, Fox J, Smith C
HIV Med. 2022; 23(8):929-930.
PMID: 35194929
PMC: 9111571.
DOI: 10.1111/hiv.13278.
Diagnosis delays in the UK according to pre or postmigration acquisition of HIV.
Stirrup O, Tostevin A, Ragonnet-Cronin M, Volz E, Burns F, Delpech V
AIDS. 2022; 36(3):415-422.
PMID: 35084383
PMC: 7612284.
DOI: 10.1097/QAD.0000000000003110.
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management.
Heskin J, Pallett S, Mughal N, Davies G, Moore L, Rayment M
Lancet. 2022; 399(10319):21-22.
PMID: 34973713
PMC: 8718360.
DOI: 10.1016/S0140-6736(21)02657-X.
Efavirenz Is Not Associated with an Increased Risk of Depressive Disorders in Patients Living with HIV: An 11-Year Population-Based Study in Taiwan.
Li C, Chen Y, Lee N, Chen P, Li M, Li C
Healthcare (Basel). 2021; 9(12).
PMID: 34946352
PMC: 8701138.
DOI: 10.3390/healthcare9121625.
Virological measures and factors associated with outcomes, and missing outcome data in HIV clinical trials: a methodological study.
Youssef M, Zani B, Olaiya O, Soliman M, Mbuagbaw L
BMJ Open. 2021; 11(10):e039462.
PMID: 34697107
PMC: 8547356.
DOI: 10.1136/bmjopen-2020-039462.
Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication Fitness.
Martin S, Cane P, Pillay D, Mbisa J
Pathogens. 2021; 10(9).
PMID: 34578103
PMC: 8470981.
DOI: 10.3390/pathogens10091070.
Trends in undiagnosed HIV prevalence in England and implications for eliminating HIV transmission by 2030: an evidence synthesis model.
Presanis A, Harris R, Kirwan P, Miltz A, Croxford S, Heinsbroek E
Lancet Public Health. 2021; 6(10):e739-e751.
PMID: 34563281
PMC: 8481938.
DOI: 10.1016/S2468-2667(21)00142-0.
Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV and Aging Workshop.
Kamkwalala A, Garg A, Roy U, Matthews A, Castillo-Mancilla J, Lake J
AIDS Res Hum Retroviruses. 2021; 37(11):807-820.
PMID: 34405689
PMC: 8817696.
DOI: 10.1089/AID.2021.0059.
Tracking elimination of HIV transmission in men who have sex with men in England: a modelling study.
Brizzi F, Birrell P, Kirwan P, Ogaz D, Brown A, Delpech V
Lancet HIV. 2021; 8(7):e440-e448.
PMID: 34118196
PMC: 8238681.
DOI: 10.1016/S2352-3018(21)00044-8.
High frequency of potential phosphodiesterase type 5 inhibitor drug interactions in males with HIV infection and erectile dysfunction.
Cota J, Benavides T, Fields J, Jansen N, Ganesan A, Colombo R
PLoS One. 2021; 16(5):e0250607.
PMID: 33956843
PMC: 8101910.
DOI: 10.1371/journal.pone.0250607.
